The 3D structure of the drug-protein complex can precisely reveal how a drug binds to and acts on a target protein. These details are useful in guiding the design and modification of more effective drug candidates. Artificial Intelligence-Driven Design (AIDD) and Structure-based Drug Design (SBDD) have become increasingly powerful methods for drug research and development. Advantages of drug design and screening based on the three-dimensional atomic structure of proteins:

1.Obtain the binding mode and interaction between drugs and target proteins;

2.Guide on how to design/modify more effective new drug molecules.

Alphelix focuses on structural biology of membrane protein using crystallography and cryo-EM techniques. By utilizing the AIDD/SBDD technology platform jointly established with our partner DP Technology, Alphelix will assist global clients in efficient drug screening and elucidation of mechanisms of action, AIDD, and SBDD, thereby accelerating innovation and reducing costs.

Services and Duration